Switch to
More onapp

Natco Pharma Ltd

NATCOPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,219 cr, stock is ranked 314
Low RiskStock is 1.72x as volatile as Nifty
605.808.75 (-1.42%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,219 cr, stock is ranked 314
Low RiskStock is 1.72x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
65.99
PB RatioPB Ratio
2.63
Dividend YieldDiv. Yield
0.73%
Sector PESector PE
34.97
Sector PBSector PB
4.27
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

36%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Brands

Natco Pharma

Pharmaceutical company

Investor PresentationView older 

Aug 10, 2022

PDF
View Older Presentations

Brands

Natco Pharma

Pharmaceutical company

Financial TrendFinancial statements 

20192020202120222.222.022.162.040.640.460.440.17
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Annual General Meeting 
Announced OnSep 30, 2022

Natco Pharma Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 30-Sep-2022 | Download

Natco Pharma Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 30-Sep-2022 | Download

Annual General Meeting 
Announced OnSep 30, 2022

Natco Pharma Limited has informed the Exchange about Proceedings of Annual General Meeting held on 30-Sep-2022 | Download

Natco Pharma Limited has informed the Exchange about Proceedings of Annual General Meeting held on 30-Sep-2022 | Download

Cash Dividend 
Ex. DateAug 19, 2022

Interim • Div/Share: ₹ 3.5

See all events